Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In-silico analysis of deleterious non-synonymous SNPs in the human AVPR1a gene linked to autism. | BMC Genomics | 2025 | 40375167 | PubTator, text mining | PubMed |
| Boosting Tolvaptan Tolerance in ADPKD: Low-Dose Hydrochlorothiazide Improves Patient Well-being Without Compromising Efficacy - A Case Report. | G Ital Nefrol | 2025 | 40332974 | PubTator, text mining | PubMed |
| A Pedigree Study of Hereditary Diabetes Insipidus Caused by X Chromosome AVPR2 Gene Mutation. | Int Med Case Rep J | 2025 | 40330118 | PubTator, text mining | PubMed |
| Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin. | Nat Commun | 2025 | 40274867 | PubTator, text mining | PubMed |
| Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances. | Ren Fail | 2025 | 40268755 | PubTator, text mining | PubMed |
| Semiartificial Photoelectrochemistry for CO2-Mediated Enantioselective Organic Synthesis. | J Am Chem Soc | 2025 | 40231652 | PubTator, text mining | PubMed |
| Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series. | CEN Case Rep | 2025 | 40214869 | PubTator, text mining | PubMed |
| Germline-derived GNAS-Gsα variants associated with both gain-of-function and loss-of-function phenotypes. | Eur J Endocrinol | 2025 | 40172207 | PubTator, text mining | PubMed |
| Sustained Gαs signaling mediated by vasopressin type 2 receptors is ligand dependent but endocytosis and β-arrestin independent. | Sci Signal | 2025 | 40136046 | PubTator, text mining | PubMed |
| A Metal-Organic Framework with Mixed Electron Donor TTF and Electron Acceptor NDI Ligands for High-Performance Hybrid Lithium-Ion Capacitors. | Inorg Chem | 2025 | 40079050 | PubTator, text mining | PubMed |
| The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD. | Nephrol Dial Transplant | 2025 | 40052348 | PubTator, text mining | PubMed |
| Nephrogenic Diabetes Insipidus Affecting Three Males in Two Generations-Case Report and Review of the Literature. | Children (Basel) | 2025 | 40003297 | PubTator, text mining | PubMed |
| Clinical and Molecular Genetic Analyses of a Girl With Isolated Nephrogenic Diabetes Insipidus due to Contiguous Gene Deletion Involving AVPR2 and L1CAM. | Am J Med Genet A | 2025 | 39992048 | PubTator, text mining | PubMed |
| Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update. | BMC Nephrol | 2025 | 39953521 | PubTator, text mining | PubMed |
Designing pillar-layered metal-organic frameworks with photo-induced electron transfer interactions between ligands for enhanced photodynamic sterilization and photocatalytic degradation of dyes and antibiotics. | J Colloid Interface Sci | 2025 | 39855091 | PubTator, text mining | PubMed |
| A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor. | Pharmacol Res | 2025 | 39800176 | PubTator, text mining | PubMed |
| Arginine vasopressin and angiotensin II coregulate Aquaporin 2 expression in M-1 cells. | Biochem Biophys Res Commun | 2025 | 39740402 | PubTator, text mining | PubMed |
| Unveiling the substantial role of rutin in the management of drug-induced nephropathy using network pharmacology and molecular docking. | Int Immunopharmacol | 2025 | 39733639 | PubTator, text mining | PubMed |
| Nephrogenic diabetes insipidus results from a novel in-frame deletion of AVPR2 gene in monozygotic-twin boys and their mother and grandmother. | J Pediatr Endocrinol Metab | 2025 | 39648407 | PubTator, text mining | PubMed |
| The natural history of untreated X-linked nephrogenic diabetes insipidus with mutation in the vasopressin V2 receptor gene. | CEN Case Rep | 2025 | 39644399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=6